Amplifold, a Munich-based BioTech startup developing rapid diagnostic tests utilizing DNA-origami nanotechnology, has announced the closing of an oversubscribed €5…
Read More

Amplifold, a Munich-based BioTech startup developing rapid diagnostic tests utilizing DNA-origami nanotechnology, has announced the closing of an oversubscribed €5…
Read More